BNRE-A:NYE-Brookfield Reinsurance Ltd. (USD)

COMMON STOCK | Insurance - Reinsurance |

Last Closing

USD 0

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Insurance - Reinsurance

Symbol Name Price(Change) Market Cap
RNR-PF RenaissanceRe Holdings Ltd

-0.10 (-0.40%)

USD 7.82B
SPNT Siriuspoint Ltd

-0.07 (-0.49%)

USD 2.42B
HG Hamilton Insurance Group, Ltd.

+0.39 (+2.19%)

USD 1.98B
PRE-PJ PartnerRe Ltd.

-0.05 (-0.28%)

N/A
RNR-PG RenaissanceRe Holdings Ltd.

+0.05 (+0.27%)

N/A
SPNT-PB SiriusPoint Ltd.

-0.06 (-0.24%)

N/A
RGA Reinsurance Group of America

-1.62 (-0.74%)

N/A
RNR Renaissancere Holdings Ltd

-2.42 (-0.91%)

N/A
EG Everest Group Ltd

-1.89 (-0.49%)

N/A

ETFs Containing BNRE-A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Reinsurance) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return 0.60% 33% F 13% F
Total Return 0.60% 18% F 24% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike